School of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen, UK.
NHS Education for Scotland, Glasgow, UK.
Int J Clin Pharm. 2022 Oct;44(5):1195-1204. doi: 10.1007/s11096-022-01467-8. Epub 2022 Aug 11.
Scottish Government is increasing independent prescribers (IP) in community pharmacy (CP). A new preceptorship model using IPs as Designated Prescribing Practitioners (DPPs) has been introduced.
To investigate stakeholder views of implementation of a novel regulator mandated IP course preceptorship model.
A theory-based online pre-piloted survey of stakeholders including e.g. directors of pharmacy, prescribing, education leads, policy & strategy leads and CPs. Questionnaire development used Consolidated Framework for Implementation Research (CFIR) and a DPP Competency Framework. Data were analysed descriptively and presented with mapping to CFIR constructs.
Of ninety-nine responses 82.5% (80/97) responded 'yes' to '..abilities in reporting concerns..' and 53.1% (51/96) indicating 'no' to '..anticipated issues with clinical and diagnostic skills'. CFIR related facilitators included agreement that; there was tension for change with 84 (85%) indicating '….urgent need to implement role …', that incentives are likely to help (6566%) and small pilots would help (8588%). Barriers were evident related to 'unsure' responses about sufficiency of; DPP capacity (39/97, 40.2%), time (48/96, 50%) and support and resources (4445%) to undertake the role. Concerns were expressed with 81 (83%) in agreement or unsure that leadership commitment may be lacking and 48 (48.9%) were 'unsure' about availability of good training for the DPP role.
There was DPP role positivity but expressed barriers and facilitators at policy, organisational and individual practitioner levels needing further consideration. Further research is warranted on uptake and embedding of the role.
苏格兰政府正在增加社区药剂师(CP)中的独立处方者(IP)。已经引入了一种使用 IP 作为指定处方执业者(DPP)的新的监督模式。
调查利益相关者对实施新的监管授权的 IP 课程监督模式的看法。
使用综合实施研究框架(CFIR)和 DPP 能力框架,对包括药剂师主任、处方、教育负责人、政策和战略负责人以及 CP 等利益相关者进行了基于理论的在线预试点调查。问卷开发。使用综合实施研究框架(CFIR)和 DPP 能力框架。对数据进行描述性分析,并与 CFIR 结构进行映射。
在 99 份回应中,82.5%(80/97)对“..报告关注的能力..”做出了“是”的回应,而 53.1%(51/96)对“..预期的临床和诊断技能问题..”做出了“否”的回应。与 CFIR 相关的促进因素包括一致认为;有 84 人(85%)表示“…迫切需要实施该角色…”,激励措施可能会有所帮助(6566%),并且小型试点将有所帮助(8588%)。存在明显的障碍,与 DPP 能力(39/97,40.2%)、时间(48/96,50%)和支持资源(4445%)是否足以承担该角色的“不确定”反应有关。有 81 人(83%)表示同意或不确定领导承诺可能不足,并且有 48 人(48.9%)对 DPP 角色的良好培训是否可用表示“不确定”。
虽然对 DPP 角色持积极态度,但在政策、组织和个体从业者层面上表达了障碍和促进因素,需要进一步考虑。需要进一步研究该角色的采用和实施情况。